Associate Professor, Medicine, University Massachusetts Medical School
Gastroenterology
Dr. Graham F. Barnard, MD
|
|
Give Review
Graham Barnard works in the field of Gastroenterology. He attended Stanford University School of Medicine. Stanford University School of Medicine is a top medical university. Stanford University School of Medicine is ranked 2 in research and 25 in primary care medicine He received 2 awards: "Regional Top Doctor" and "Meaningful Use Stage 1 Certification". Graham Barnard is also published. He has 75 publications published. The lastest publication: "Vascular endothelial growth factor/vascular permeability factor mRNA expression in patients with chronic hepatitis C and hepatocellular carcinoma.' Graham F. Barnard accepts Medicare payments and is listed with Medicare.gov.
Publications
- CD13 is a therapeutic target in human liver Cancer stem cells.
- Endoscopic diagnosis and removal of Ascaris lumbricoides during colonoscopy for polyp surveillance (with video).
- Characterization of a side population of cancer cells from human gastrointestinal System.
- FHIT is up-regulated by inflammatory stimuli and inhibits prostaglandin E2-mediated Cancer progression.
- The epidermal growth factor receptor gene sequence is highly conserved in primary gastric Cancers.
- Epidermal growth factor receptor gene is highly conserved in pancreatic Cancer cells.
- Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric Cancer.
- Effect of concomitant polyethylene glycol and celecoxib on colonic aberrant crypt foci and tumors in F344 rats.
- Somatic mutations of epidermal growth factor receptor in Colorectal carcinoma.
- Coexpression of matrix metalloproteinase-7 (MMP-7) and epidermal growth factor (EGF) receptor in Colorectal cancer: an EGF receptor tyrosine kinase inhibitor is effect...
- CD4+ T-cell lymphoproliferative disorder of the gut clinically mimicking celiac sprue.
- Nucleotide and deduced amino acid sequence of human ribosomal protein L18.
- Regulation of lipoprotein receptors on rat hepatomas in vivo.
- Reduced binding and removal of chylomicron remnants by ethionine-induced premalignant liver.
- Human ribosomal protein L37 has motifs predicting serine/threonine phosphorylation and a zinc-finger domain.
- PCR product sequencing with [alpha-33P] and [alpha-32P]dATP.
- Massive volume paracentesis (up to 41 liters) for the outpatient management of ascites.
- Primary aortoDuodenal fistula after radiotherapy.
- Sulfone Syndrome in a patient receiving steroids for pemphigus.
- Lipoprotein metabolism by rat hepatomas. Studies on the etiology of defective dietary feedback inhibition of cholesterol synthesis.
- Diagnosis of porphyric Syndromes: a practical approach in the era of molecular biology.
- Quantitation of liver RNA.
- T- and B-cell markers in colonic nodular lymphoid hyperplasia in HIV infection.
- Multiple tumor-suppressor-1 gene and Esophageal-carcinoma.
- Prothymosin-alpha mRNA expression correlates with that of c-myc in human colon Cancer.
- Dysplasia and carcinoma in small Colorectal polyps.
- Ubiquitin fusion proteins are overexpressed in colon Cancer but not in gastric Cancer.
- Rectal Dieulafoy's or angiodysplasia?
- Endoscopic ultrasound appearance of watermelon stomach.
- Clinical significance of integrin alpha 6 mRNA expression in Gastric carcinoma.
- alpha6 integrin expression in Esophageal carcinoma.
- Increased expression of human ribosomal phosphoprotein P0 messenger RNA in hepatocellular carcinoma and colon carcinoma.
- The significance of carbonic anhydrase expression in human Colorectal cancer.
- Inflammatory markers in chronic hepatitis C.
- Gastric and hepatocellular carcinomas do not overexpress the same ribosomal protein messenger RNAs as colonic carcinoma.
- Vascular endothelial growth factor/vascular permeability factor mRNA expression in patients with chronic hepatitis C and hepatocellular carcinoma.
- Expression of MAGE genes in human Colorectal carcinoma.
- Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early Systemic disease.
- RT-PCR detection of breast Cancer cells in sentinel lymph modes.
- Loss of hIRH mRNA expression from premalignant adenomas and malignant cell lines.
- Reduced expression of the CXC chemokine hIRH/SDF-1alpha mRNA in hepatoma and Digestive tract cancer.
- Differential display and integrin alpha 6 messenger RNA overexpression in hepatocellular carcinoma.
- Florid angiogenesis in mucosa surrounding an ileal carcinoid tumor expressing transforming growth factor-alpha.
- Colonic mucosal appearance of Tangier Disease in a new patient.
- Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with...
- Hepatoma-derived growth factor is associated with reduced sensitivity to irradiation in esophageal Cancer.
- Interleukin-8 and hIRH (SDF1-alpha/PBSF) mRNA expression and histological activity index in patients with chronic hepatitis C.
- Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas.
- Lack of DMBT1 expression in oesophageal, gastric and colon Cancers.
- Interleukin-8 and SDF1-alpha mRNA expression in colonic biopsies from patients with inflammatory bowel Disease.
- Relaxation of insulin-like growth factor 2 gene imprinting in esophageal Cancer.
- IFN-alpha receptor mRNA expression in a United States sample with predominantly genotype 1a/I chronic hepatitis C liver biopsies correlates with response to IFN therapy.
- Clinical significance of K-Ras mutations in intraoperative tumor drainage blood from patients with Colorectal carcinoma.
- Detection of Cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction.
- Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal Cancer is related to Cancer aggressiveness.
- Glyceraldehyde-3-phosphate dehydrogenase mRNA expression in hepatocellular carcinoma.
- Angiopoietin-2 is related to tumor angiogenesis in Gastric carcinoma: possible in vivo regulation via induction of proteases.
- Angiogenin expression in human Colorectal cancer: the role of focal macrophage infiltration.
- Motility related protein 1 (MRP1/CD9) expression in colon Cancer.
- Reduced expression of the CXCR4 receptor mRNA in hepatocellular carcinoma and lack of inducibility of its ligand alpha-chemokine hIRH/SDF1alpha/PBSF in vitro.
- CXCR4 mRNA expression in colon, esophageal and gastric Cancers and hepatitis C infected liver.
- Loss of chemokine SDF-1alpha-mediated CXCR4 signalling and receptor internalization in human hepatoma cell line HepG2.
- Heparanase expression in clinical Digestive malignancies.
- Prognostic impact of tissue inhibitor of matrix metalloproteinase-1 in Esophageal carcinoma.
- Genetic polymorphism of N-acetyltransferase 2 in patients with esophageal Cancer.
- Overexpression of HRad17 mRNA in human breast Cancer: correlation with lymph node metastasis.
- Expression of tissue inhibitor of matrix metalloproteinase-1 in human breast carcinoma.
- L-myc restriction fragment length polymorphism in Japanese patients with esophageal Cancer.
- Regional expression of CXCL12/CXCR4 in liver and hepatocellular carcinoma and cell-cycle variation during in vitro differentiation.
- A gene-expression signature can quantify the degree of hepatic fibrosis in the rat.
- Identification of molecular markers for metastasis-related genes in primary breast Cancer cells.
- Genetic susceptibility of catechol-O-methyltransferase polymorphism in Japanese patients with breast Cancer.
- Identification of the expression profile of apoptotic esophageal Cancer cells by adenoviral-fragile histidine triad treatment.
- A specific gene-expression signature quantifies the degree of hepatic fibrosis in patients with chronic liver Disease.
Schools
Stanford University School Of Medicine
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- ERCP (Endoscopic Retrograde Cholangiopancreatography)
- Fecal Impaction Removal
- View All
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
- Transplant Hepatology
Accepted Insurances
Awards
- Regional Top Doctor
- Meaningful Use Stage 1 Certification
Education
-
Brigham and Women's Hospital -
Beth Israel Deaconess Medical Center -
Stanford University School of Medicine
Hospital
-
UMass Memorial Medical Center
Drug Facts
| NPI NUMBER | 1942284369 | |
| NPPES Provider LastName | BARNARD | |
| NPPES Provider FirstName | GRAHAM | |
| NPPES Provider ZIPCode | 016550002 | |
| NPPES Provider State | MA | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 1218.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 14.0 | |
| Percent Opioid Claims | 1.15 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1942284369 |
| Last Name Of The Provider | BARNARD |
| First Name Of The Provider | GRAHAM |
| View All |
Similar Doctors
|
|
Savant Mehta, BM
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bilal Gondal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher A. Marshall, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter P. Tomaiolo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kelly J. O'Callahan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew Leiter, MD |
|
|
Dr. Mitchell J. Gitkind, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George M. Tinawi, MD |
|
|
Dr. Jonathan Taylor, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Curuchi P. Anand, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael A. Papper, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John K. Zawacki, MD
This Doctor is OpenDoctor Recommended.
|